| Matthew Ryan Thigpen, | |
|
1400 S Coulter St Ste 5100, Amarillo, TX 79106-1786 | |
| (806) 414-9559 | |
| (806) 351-3765 |
| Full Name | Matthew Ryan Thigpen |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1400 S Coulter St Ste 5100, Amarillo, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700349354 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | T7058 (Texas) | Primary |
| Entity Name | Texas Tech University Health Sciences Center Amarillo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013942150 PECOS PAC ID: 9234037847 Enrollment ID: O20031220000051 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) requesting approval to begin a Phase III clinical program evaluating rifamycin SV MMX® in patients with travelers' diarrhea.
Clinicians at Ludwig-Maximilians-Universitaet in Munich have elucidated a mechanism involved in determining the lifespan of antibody-producing cells, and identified a promising new biomarker for monitoring autoimmune diseases like multiple sclerosis and lupus erythematosus.
Novartis announced today that the European Commission has approved Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For AS, this is the first new treatment advance in 16 years since the development of the current standard of care, anti-tumor necrosis factor (anti-TNF) therapy.
Sunlight Research – The Source for Patent Analysis, today announced the release of its comprehensive Stem Cell Industry Report analyzing the U.S. Stem Cell patent landscape. Stem cells are particularly attractive for use as cellular therapies because they self-renew and have the capacity to produce many different specialized cell types.
A research team led by Cary Pirone from the Department of Biological Sciences at Florida International University has identified bilirubin in the popular Bird of Paradise plant. The breakthrough study, published in the September 2010 issue of the American Society for Horticultural Science's journal HortScience, provides new insights into color production in this iconic tropical plant.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Ryan Thigpen, 1400 S Coulter St Ste 5100, Amarillo, TX 79106-1786 Ph: (806) 414-9559 | Matthew Ryan Thigpen, 1400 S Coulter St Ste 5100, Amarillo, TX 79106-1786 Ph: (806) 414-9559 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) requesting approval to begin a Phase III clinical program evaluating rifamycin SV MMX® in patients with travelers' diarrhea.
Clinicians at Ludwig-Maximilians-Universitaet in Munich have elucidated a mechanism involved in determining the lifespan of antibody-producing cells, and identified a promising new biomarker for monitoring autoimmune diseases like multiple sclerosis and lupus erythematosus.
Novartis announced today that the European Commission has approved Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For AS, this is the first new treatment advance in 16 years since the development of the current standard of care, anti-tumor necrosis factor (anti-TNF) therapy.
Sunlight Research – The Source for Patent Analysis, today announced the release of its comprehensive Stem Cell Industry Report analyzing the U.S. Stem Cell patent landscape. Stem cells are particularly attractive for use as cellular therapies because they self-renew and have the capacity to produce many different specialized cell types.
A research team led by Cary Pirone from the Department of Biological Sciences at Florida International University has identified bilirubin in the popular Bird of Paradise plant. The breakthrough study, published in the September 2010 issue of the American Society for Horticultural Science's journal HortScience, provides new insights into color production in this iconic tropical plant.
› Verified 4 days ago
Elizabeth Tu, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 S Coulter St Ste 5100, Amarillo, TX 79106 Phone: 806-414-9559 Fax: 806-351-3767 | |
Dr. David Thetford, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 275 Casino Dr, Amarillo, TX 79118 Phone: 806-884-9943 | |
Brian Gillette, MHS, PA-C Family Medicine Medicare: Medicare Enrolled Practice Location: 1100 S Coulter St, Amarillo, TX 79106 Phone: 806-468-9700 | |
Pamela K Banister, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3501 S Soncy Rd Ste 150, Amarillo, TX 79119 Phone: 806-212-6353 Fax: 806-212-0558 | |
Dr. Wesley Scott Nickens, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2701 S Georgia St, Amarillo, TX 79109 Phone: 806-350-8980 Fax: 806-350-7573 | |
Genkai Jason Huang, Family Medicine Medicare: Medicare Enrolled Practice Location: 2701 S Georgia St, Amarillo, TX 79109 Phone: 806-350-8980 Fax: 806-350-7573 | |
Gary J Hilton, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2701 S Georgia St, Amarillo, TX 79109 Phone: 806-350-3000 Fax: 806-350-3337 |